Crestchem Q4 FY26 profit rises 81%, declares final dividend

Crestchem Limited reported a net profit of ₹110.38 lakh for the quarter ended March 31, 2026, compared to ₹61.04 lakh in the corresponding period of the previous year. Revenue from operations for the quarter stood at ₹1,022.53 lakh, up from ₹723.20 lakh in Q4 FY25. For the full financial year FY26, the company recorded a net profit of ₹271.35 lakh on revenue of ₹2,960.74 lakh.

The Board of Directors, meeting on May 29, 2026, approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The board recommended a final dividend of ₹1.50 per equity share, or 15%, for the financial year 2025-26. This payout is subject to shareholder approval at the upcoming Annual General Meeting.

During the year, the company incorporated a subsidiary, Oleo Biosciences Private Limited, in Bangalore on March 31, 2026. Crestchem holds a 75% stake in the new entity. The subsidiary had not commenced commercial operations by the end of FY26, and no significant financial transactions were recorded other than subscription money receivables.

The board also approved the reappointment of key managerial personnel. Mr. Dipak Narendraprasad Patel, Mrs. Parul Dipak Patel, and Mrs. Tansi Nimit Patel were reappointed for five-year terms effective from October 1, 2026, and April 1, 2026, respectively. Furthermore, the board authorized an investment of up to ₹2.25 crore in the new subsidiary via loans or equity.

Financial Performance

The company's earnings per share (EPS) for the quarter ended March 31, 2026, increased to ₹3.67 from ₹2.03 in the same quarter of the previous year. Total income for the quarter rose to ₹1,042.91 lakh from ₹737.27 lakh. For the full year, EPS was recorded at ₹9.03, slightly lower than the ₹9.09 reported in FY25.

Standalone Financial Results (₹ in Lacs)

Particulars	Quarter Ended Mar 31, 2026	Quarter Ended Mar 31, 2025	Year Ended Mar 31, 2026	Year Ended Mar 31, 2025
Revenue from operations	1,022.53	723.20	2,960.74	2,507.72
Total Income	1,042.91	737.27	3,026.62	2,551.59
Total Expenses	885.16	664.67	2,650.88	2,185.91
Profit before tax	157.75	72.59	375.75	365.68
Net Profit	110.38	61.04	271.35	272.65

The statutory auditors, M/s. Samir M. Shah & Associates, issued an audit report with an unmodified opinion on the standalone and consolidated financial results.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-3.79%	-2.83%	-7.87%	+11.40%	-26.33%	+131.96%

Crestchem Limited has approved a dividend for the financial year 2025-26 and fixed the record date for its payment. The decision was taken during a board meeting held on July 04, 2026, which also finalized the date for the company's 34th Annual General Meeting (AGM). The board approved opening a dividend account with HDFC Bank to facilitate the payout to shareholders.

Key Decisions and Approvals

The Board of Directors approved several reports required for the upcoming AGM, including the Board of Directors report, the Corporate Governance report, and the Management Discussion & Analysis Report. Additionally, the board approved the Calendar of Events for the AGM and the notice for the meeting.

Corporate Actions

Fix the date of the 34th AGM and approve the notice.
Approve the Board of Directors report.
Approve the Corporate Governance report.
Open a dividend account with HDFC Bank.
Approve the Management Discussion & Analysis Report.
Fix book closure and record date for dividend payment for F.Y. 2025-26.
Approve the Calendar of Events for the AGM.
Arrange a Video Conference Meeting or OVAM with CDSL.

The 34th AGM is scheduled for Thursday, August 06, 2026. The meeting was held at 12.15 Noon and concluded with a vote of thanks to the Chair at 2.30 PM. The intimation regarding the outcome was submitted to BSE Limited by Nitin S. Shah, Company Secretary & Compliance Officer.